TORONTO, March 5 /CNW/ - DELISTING REVIEW - Fralex Therapeutics Inc. (the "Company") - Further to TSX Bulletin 2008-1286 dated November 13, 2008, TSX has extended its review of the eligibility of the common shares of the Company (Symbol: FXI) for continued listing for 30 days.

About TMX Group (TSX-X)

TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tsx.com.